Future of angiopoietin-like protein 3 inhibitors as a therapeutic agent
{{output}}
Purpose of review: Triglyceride-rich lipoproteins (TRLs) and LDL remain major drivers of atherosclerotic cardiovascular disease, and angiopoietin-like protein 3 (ANGPTL3) has emerged as a promising target to lower both triglyceri... ...
